Where Will GW Pharmaceuticals Be in 5 Years?

Where Will GW Pharmaceuticals Be in 5 Years?

Source: 
Motley Fool
snippet: 

GW Pharmaceuticals (NASDAQ: GWPH) paved the way for modulating the cannabinoid pathway and turning that field of science into valuable prescription therapeutics. Over the past five years, GW transitioned from a promising idea to a commercial reality with two approved drugs in the U.S. and Europe.